Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Unity Biotechnology Inc shares valued at $18,388 were sold by Nguyen Alexander Hieu on Apr 02 ’25. At $1.03 per share, Nguyen Alexander Hieu sold 17,852 shares. The insider’s holdings dropped to 48,753 shares worth approximately $38514.87 following the completion of this transaction.
Also, Nguyen Alexander Hieu purchased 17,852 shares, netting a total of over 18,305 in proceeds.
Before that, Sullivan Lynne Marie had sold 21,867 shares from its account. In a trade valued at $22,523, the CFO & Head of Corp. Dev. traded Unity Biotechnology Inc shares for $1.03 each. Upon closing the transaction, the insider’s holdings decreased to 21,867 shares, worth approximately $78134.95.
As published in a research note from H.C. Wainwright on May 27, 2025, Unity Biotechnology Inc [UBX] has been rated down from a Buy to a Neutral and the price target has been revised to $2. Analysts at Mizuho downgraded the stock from ‘”an Outperform”‘ to ‘”a Neutral”‘ outlook in a report released in mid May. As of August 22, 2024, Rodman & Renshaw has initiated its “Buy” rating for UBX. Earlier on November 16, 2023, Wedbush upgraded its rating. Their new recommendation was “an Outperform” for UBX stock which previously was a “a Neutral”.
Analyzing UBX Stock Performance
On last trading session,, Unity Biotechnology Inc [NASDAQ: UBX] rose 1.83% to $0.79. During the last five days, there has been a drop of approximately -10.15%. Over the course of the year, Unity Biotechnology Inc shares have dropped approximately -19.07%. Shares of the company reached a 52-week high of $3.1000 on 01/23/25 and a 52-week low of $0.6600 on 05/29/25.
Support And Resistance Levels for Unity Biotechnology Inc (UBX)
According to the 24-hour chart, there is a support level at 0.7764, which, if violated, would cause prices to drop to 0.7627. In the upper region, resistance lies at 0.8075. The next price resistance is at 0.8249. RSI (Relative Strength Index) is 48.08 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Unity Biotechnology Inc (UBX)?
In terms of Unity Biotechnology Inc share price expectations, FactSet research, analysts set an average price target of 2.5 in the next 12 months, up nearly 220.51% from the previous closing price of $0.78. Analysts anticipate Unity Biotechnology Inc stock to reach 4 by 2025, with the lowest price target being 1. In spite of this, 3 analysts ranked Unity Biotechnology Inc stock as Buy at the end of 2025.
